Renaissance Technologies
PLXP

Renaissance Technologies’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Renaissance Technologies’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-37,000
Closed -$5K – 4442
2023
Q1 		$5K Sell
37,000
-17,500
-32% -$3.56K ﹤0.01% 3917
2022
Q4 		$9K Buy
+54,500
New +$22.8K ﹤0.01% 4042
2021
Q3 		– Sell
-208,983
Closed -$2.88M – 3973
2021
Q2 		$2.88M Sell
208,983
-69,568
-25% -$824K ﹤0.01% 2004
2021
Q1 		$2.52M Buy
278,551
+139,468
+100% +$1.02M ﹤0.01% 2070
2020
Q4 		$768K Buy
139,083
+61,400
+79% +$272K ﹤0.01% 2630
2020
Q3 		$251K Buy
77,683
+3,700
+5% +$12.4K ﹤0.01% 3055
2020
Q2 		$240K Sell
73,983
-417
-0.6% -$1.26K ﹤0.01% 3112
2020
Q1 		$167K Buy
74,400
+4,289
+6% +$19.6K ﹤0.01% 3132
2019
Q4 		$306K Buy
70,111
+1,400
+2% +$6.58K ﹤0.01% 3067
2019
Q3 		$350K Buy
68,711
+4,000
+6% +$23.3K ﹤0.01% 2991
2019
Q2 		$466K Buy
64,711
+6,099
+10% +$33.1K ﹤0.01% 3018
2019
Q1 		$308K Buy
58,612
+14,900
+34% +$72.9K ﹤0.01% 3083
2018
Q4 		$67K Buy
43,712
+2,000
+5% +$7.13K ﹤0.01% 3268
2018
Q3 		$169K Buy
41,712
+2,400
+6% +$9.03K ﹤0.01% 3178
2018
Q2 		$153K Buy
39,312
+1,100
+3% +$4.49K ﹤0.01% 3105
2018
Q1 		$128K Buy
38,212
+5,700
+18% +$36.1K ﹤0.01% 3239
2017
Q4 		$224K Buy
32,512
+10,000
+44% +$69.4K ﹤0.01% 3103
2017
Q3 		$145K Buy
+22,512
New +$144K ﹤0.01% 3055
2016
Q4 		– Sell
-5,275
Closed -$612K – 3533
2016
Q3 		$612K Buy
5,275
+800
+18% +$78K ﹤0.01% 2751
2016
Q2 		$355K Buy
4,475
+1,237
+38% +$107K ﹤0.01% 2900
2016
Q1 		$246K Buy
3,238
+1,100
+51% +$69.9K ﹤0.01% 3033
2015
Q4 		$192K Buy
2,138
+413
+24% +$39.6K ﹤0.01% 3004
2015
Q3 		$193K Buy
+1,725
New +$199K ﹤0.01% 2904

Other funds holding PLXP

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.28B AUM 38.1% 1-Year Est. Return

Renaissance Technologies's PLXP Position: Q2 2023 in Review

Renaissance Technologies sold out of PLx Pharma Inc. Common Stock (PLXP) in Q2 2023, closing a stake of 37,000 shares — an estimated $5K sold.

Renaissance Technologies first reported a position in PLXP in Q3 2015 and held it in 23 quarters. The position peaked at $2.88M in Q2 2021. 4 funds tracked by Wall St. Rank hold PLXP as of Q2 2023.

  • Renaissance Technologies reported no remaining PLx Pharma Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Renaissance Technologies sold 37,000 PLx Pharma Inc. Common Stock shares in Q2 2023, an estimated $5K.
  • Renaissance Technologies first reported a position in PLx Pharma Inc. Common Stock in Q3 2015 and held it in 23 quarters.
  • Renaissance Technologies's PLx Pharma Inc. Common Stock position peaked at $2.88M in Q2 2021.
  • 4 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q2 2023.

Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.